Role and Outcome of Endovascular Revascularization of Chronic Limb Ischaemia
1 other identifier
observational
100
0 countries
N/A
Brief Summary
identify the safety and efficacy of percutaneous transluminal angioplasty in critical limb ischaemia patients with chronic kidney dieases
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2022
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedFirst Posted
Study publicly available on registry
December 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedDecember 8, 2022
December 1, 2022
9 months
November 26, 2022
December 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
one year evaluation for maintaining vessel patency without restenosis or need for re intervention in 100 participants
all patients will be scheduled for follow up visits every 3 months for 1 year assessing primary patency and major adverse limb events. duplex scanning will be performed for all patients
baseline
Eligibility Criteria
all patients fulfilled these criteria will be included in this study as an availability sample for year duration sample size : 100 patients
You may qualify if:
- all patients with chronic kidney diseases on medical treatment or on dialysis and have critical limb ischaemia
You may not qualify if:
- patients with acute renal failure and lower limb ischaemia.
- chronic kidney diseased patients underwent previous intervention or surgery for lower limb ischaemia.
- patients presented with acute limb ischaemia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Dayama A, Tsilimparis N, Kolakowski S, Matolo NM, Humphries MD. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease. J Vasc Surg. 2019 Jan;69(1):156-163.e1. doi: 10.1016/j.jvs.2018.05.244.
PMID: 30579443BACKGROUNDImamura T. Optimal therapeutic strategy for those with chronic kidney disease and peripheral artery disease receiving peripheral vascular intervention. Clin Cardiol. 2020 Dec;43(12):1348. doi: 10.1002/clc.23483. Epub 2020 Oct 19. No abstract available.
PMID: 33073876BACKGROUNDMoussa Pacha H, Al-Khadra Y, Darmoch F, Soud M, Mamas MA, Moussa Pacha A, Zaitoun A, Kaki A, AlJaroudi WA, Alraies MC. In-hospital outcome of peripheral vascular intervention in dialysis-dependent end-stage renal disease patients. Catheter Cardiovasc Interv. 2020 Feb 15;95(3):E84-E95. doi: 10.1002/ccd.28522. Epub 2019 Oct 21.
PMID: 31631511BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
November 26, 2022
First Posted
December 8, 2022
Study Start
December 1, 2022
Primary Completion
September 1, 2023
Study Completion
October 1, 2023
Last Updated
December 8, 2022
Record last verified: 2022-12